These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 31308421)

  • 1. Differential prognostic impact of platelet-derived growth factor receptor expression in NSCLC.
    Kilvaer TK; Rakaee M; Hellevik T; Vik J; Petris L; Donnem T; Strell C; Ostman A; Busund LR; Martinez-Zubiaurre I
    Sci Rep; 2019 Jul; 9(1):10163. PubMed ID: 31308421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic impact of platelet-derived growth factors in non-small cell lung cancer tumor and stromal cells.
    Donnem T; Al-Saad S; Al-Shibli K; Andersen S; Busund LT; Bremnes RM
    J Thorac Oncol; 2008 Sep; 3(9):963-70. PubMed ID: 18758297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined anti-PDGFRalpha and PDGFRbeta targeting in non-small cell lung cancer.
    Reinmuth N; Liersch R; Raedel M; Fehrmann F; Fehrmann N; Bayer M; Schwoeppe C; Kessler T; Berdel W; Thomas M; Mesters RM
    Int J Cancer; 2009 Apr; 124(7):1535-44. PubMed ID: 19115205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical overexpression of platelet-derived growth factor receptor-beta (PDGFR-β) is associated with PDGFRB gene copy number gain in sarcomatoid non-small-cell lung cancer.
    Tsao AS; Wei W; Kuhn E; Spencer L; Solis LM; Suraokar M; Lee JJ; Hong WK; Wistuba II
    Clin Lung Cancer; 2011 Nov; 12(6):369-74. PubMed ID: 21729646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic impact of fibroblast growth factor 2 in non-small cell lung cancer: coexpression with VEGFR-3 and PDGF-B predicts poor survival.
    Donnem T; Al-Shibli K; Al-Saad S; Busund LT; Bremnes RM
    J Thorac Oncol; 2009 May; 4(5):578-85. PubMed ID: 19318994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stromal platelet-derived growth factor receptor α (PDGFRα) provides a therapeutic target independent of tumor cell PDGFRα expression in lung cancer xenografts.
    Gerber DE; Gupta P; Dellinger MT; Toombs JE; Peyton M; Duignan I; Malaby J; Bailey T; Burns C; Brekken RA; Loizos N
    Mol Cancer Ther; 2012 Nov; 11(11):2473-82. PubMed ID: 22933705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The PDGF pathway in breast cancer is linked to tumour aggressiveness, triple-negative subtype and early recurrence.
    Jansson S; Aaltonen K; Bendahl PO; Falck AK; Karlsson M; Pietras K; Rydén L
    Breast Cancer Res Treat; 2018 Jun; 169(2):231-241. PubMed ID: 29380207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct effects of ligand-induced PDGFRα and PDGFRβ signaling in the human rhabdomyosarcoma tumor cell and stroma cell compartments.
    Ehnman M; Missiaglia E; Folestad E; Selfe J; Strell C; Thway K; Brodin B; Pietras K; Shipley J; Östman A; Eriksson U
    Cancer Res; 2013 Apr; 73(7):2139-49. PubMed ID: 23338608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Epithelial-Stromal Interactions on Peritumoral Fibroblasts in Ductal Carcinoma in Situ.
    Strell C; Paulsson J; Jin SB; Tobin NP; Mezheyeuski A; Roswall P; Mutgan C; Mitsios N; Johansson H; Wickberg SM; Svedlund J; Nilsson M; Hall P; Mulder J; Radisky DC; Pietras K; Bergh J; Lendahl U; Wärnberg F; Östman A
    J Natl Cancer Inst; 2019 Sep; 111(9):983-995. PubMed ID: 30816935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High expression of PDGFR-β in prostate cancer stroma is independently associated with clinical and biochemical prostate cancer recurrence.
    Nordby Y; Richardsen E; Rakaee M; Ness N; Donnem T; Patel HR; Busund LT; Bremnes RM; Andersen S
    Sci Rep; 2017 Feb; 7():43378. PubMed ID: 28233816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapeutic alteration of VEGF, PDGF and PDGFRα/β expression under 5-FU vs. docetaxel in HPV-transformed squamous cell carcinoma compared to HPV-negative HNSCC in vitro.
    Aderhold C; Umbreit C; Faber A; Sauter A; Sommer JU; Birk R; Erben P; Hofheinz RD; Stern-Straeter J; Hörmann K; Schultz JD
    Anticancer Res; 2013 May; 33(5):1951-61. PubMed ID: 23645743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of Platelet-Derived Growth Factor and Its Receptor Are Correlated with Oral Tumorigenesis and Poor Prognosis in Oral Squamous Cell Carcinoma.
    Lin LH; Lin JS; Yang CC; Cheng HW; Chang KW; Liu CJ
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32235327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of CAF-Related Proteins Is Associated with Histologic Grade of Breast Phyllodes Tumor.
    Kim HM; Lee YK; Koo JS
    Dis Markers; 2016; 2016():4218989. PubMed ID: 27881889
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibition of PDGFR by CP-673451 induces apoptosis and increases cisplatin cytotoxicity in NSCLC cells via inhibiting the Nrf2-mediated defense mechanism.
    Yang Y; Deng Y; Chen X; Zhang J; Chen Y; Li H; Wu Q; Yang Z; Zhang L; Liu B
    Toxicol Lett; 2018 Oct; 295():88-98. PubMed ID: 29857117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer Associated Fibroblasts in Stage I-IIIA NSCLC: Prognostic Impact and Their Correlations with Tumor Molecular Markers.
    Kilvaer TK; Khanehkenari MR; Hellevik T; Al-Saad S; Paulsen EE; Bremnes RM; Busund LT; Donnem T; Martinez IZ
    PLoS One; 2015; 10(8):e0134965. PubMed ID: 26252379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PDGFRalpha/beta expression correlates with the metastatic behavior of human colorectal cancer: a possible rationale for a molecular targeting strategy.
    Wehler TC; Frerichs K; Graf C; Drescher D; Schimanski K; Biesterfeld S; Berger MR; Kanzler S; Junginger T; Galle PR; Moehler M; Gockel I; Schimanski CC
    Oncol Rep; 2008 Mar; 19(3):697-704. PubMed ID: 18288404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical and mutational analysis of PDGF and PDGFR in desmoid tumours: is there a role for tyrosine kinase inhibitors in c-kit-negative desmoid tumours?
    Liegl B; Leithner A; Bauernhofer T; Windhager R; Guelly C; Regauer S; Beham A
    Histopathology; 2006 Dec; 49(6):576-81. PubMed ID: 17163842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression and clinical significance of PDGFRalpha and PDGFRbeta in colorectal cancer].
    Zhu HT; Han J; Ma L
    Ai Zheng; 2008 Jun; 27(6):654-60. PubMed ID: 18570744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of insulin-like growth factor 1 receptor in patients with non-small cell lung cancer.
    Kim JS; Kim ES; Liu D; Lee JJ; Behrens C; Lippman SM; Hong WK; Wistuba II; Lee E; Lee HY
    Oncotarget; 2015 Jun; 6(18):16746-56. PubMed ID: 25944691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer-associated fibroblast activation predicts progression, metastasis, and prognosis of cutaneous squamous cell carcinoma.
    Knuutila JS; Riihilä P; Nissinen L; Heiskanen L; Kallionpää RE; Pellinen T; Kähäri VM
    Int J Cancer; 2024 Sep; 155(6):1112-1127. PubMed ID: 38648387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.